Skip to main content
Erschienen in: AIDS and Behavior 8/2023

24.01.2023 | Original Paper

Missed Opportunities When We Focus only on Risk: Using the Concerns Based Conversation Starter to Identify Potential PrEP Candidates

verfasst von: Megan Mueller Johnson, Noah Brooks, K Rivet Amico

Erschienen in: AIDS and Behavior | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Collection and use of self-reported HIV sexual risk-behaviors to identify pre-exposure prophylaxis (PrEP) candidates is common practice in PrEP providing and referral services. Critiques of this strategy highlight overreliance on self-report and contribution to ongoing PrEP stigma. As an alternative (or complimentary) approach, we evaluated a 5-item Concerns Based Conversation Starter (CBCS) that could be used to identify individuals who could benefit from PrEP. The CBCS was included in the 2019 cycle of the American Men’s Internet Survey. Item responses were characterized overall and in relation to CDC risk-based PrEP indication and reported willingness to use PrEP. In total, 1606 HIV-negative men who have sex with men not on PrEP were evaluated. Of these, 50% were below the age of 25, 11% Black, 16% Latino, and 64% White. Across the sample, 61% (986) met risk-based criteria for PrEP indication, 80% (1278) were identified by the CBCS, and 52% (835) were flagged by both. The CBCS uniquely identified 28% (443) for follow-up PrEP discussions that would have been missed by a risk-based only approach. Only 9% (151) of the sample had risk-based indication but did not report concerns. Over half of those flagged by the CBCS expressed willingness to use PrEP. The CBCS identified more people than a risk-based indication approach, with most also reporting an interest in using PrEP. A small percentage of risk-indicated participants were ‘missed’ by the CBCS. As PrEP options and access points expand, implementation tools like the CBCS can facilitate more wide-scale, values-focused PrEP implementation.
Literatur
2.
Zurück zum Zitat Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA : the Journal of the American Medical Association. 2019;321(9):844–5.CrossRefPubMed Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA : the Journal of the American Medical Association. 2019;321(9):844–5.CrossRefPubMed
3.
Zurück zum Zitat Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure Prophylaxis in the United States: a narrative review. Adv Therapy. 2020;37(5):1778–811.CrossRef Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure Prophylaxis in the United States: a narrative review. Adv Therapy. 2020;37(5):1778–811.CrossRef
4.
Zurück zum Zitat Centers for Disease Control and Prevention. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morbidity and mortality weekly report. 2012;61(31):586–9. Centers for Disease Control and Prevention. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morbidity and mortality weekly report. 2012;61(31):586–9.
5.
Zurück zum Zitat Centers for Disease Control and Prevention. Pre-exposure prophylaxis for the prevention of HIV infection in the United States—2017 update: a clinical practice guideline. Atlanta: CDC; 2018. Centers for Disease Control and Prevention. Pre-exposure prophylaxis for the prevention of HIV infection in the United States—2017 update: a clinical practice guideline. Atlanta: CDC; 2018.
7.
Zurück zum Zitat Centers for Disease Control and Prevention. Pre-exposure Prophylaxis for the Prevention of HIV infection in the United States – 2021 Update Clinical Practice Guideline. A clinical practice guideline: US Public Health Service; 2021. Centers for Disease Control and Prevention. Pre-exposure Prophylaxis for the Prevention of HIV infection in the United States – 2021 Update Clinical Practice Guideline. A clinical practice guideline: US Public Health Service; 2021.
8.
Zurück zum Zitat Elion R, Coleman M. The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA. Curr Opin HIV AIDS. 2016;11(1):67–73.CrossRefPubMedPubMedCentral Elion R, Coleman M. The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA. Curr Opin HIV AIDS. 2016;11(1):67–73.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Mayer KH, Chan PA, Flash RRP, Krakower CA. DS. Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States. Journal of Acquired Immune Deficiency Syndromes (1999). 2018;77(2):119 – 27. Mayer KH, Chan PA, Flash RRP, Krakower CA. DS. Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States. Journal of Acquired Immune Deficiency Syndromes (1999). 2018;77(2):119 – 27.
10.
Zurück zum Zitat Calabrese SK, Magnus M, Mayer KH, Krakower DS, Eldahan AI, Gaston Hawkins LA, et al. Putting PrEP into practice: Lessons learned from early-adopting U.S. providers’ firsthand Experiences providing HIV Pre-Exposure Prophylaxis and Associated Care. PLoS ONE. 2016;11(6):e0157324.CrossRefPubMedPubMedCentral Calabrese SK, Magnus M, Mayer KH, Krakower DS, Eldahan AI, Gaston Hawkins LA, et al. Putting PrEP into practice: Lessons learned from early-adopting U.S. providers’ firsthand Experiences providing HIV Pre-Exposure Prophylaxis and Associated Care. PLoS ONE. 2016;11(6):e0157324.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Calabrese SK, Underhill K. How Stigma surrounding the Use of HIV Preexposure Prophylaxis undermines Prevention and pleasure: a call to destigmatize “Truvada Whores”. Am J Public Health. 2015;105(10):1960–4.CrossRefPubMedPubMedCentral Calabrese SK, Underhill K. How Stigma surrounding the Use of HIV Preexposure Prophylaxis undermines Prevention and pleasure: a call to destigmatize “Truvada Whores”. Am J Public Health. 2015;105(10):1960–4.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Calabrese SK, Underhill K, Earnshaw VA, Hansen NB, Kershaw TS, Magnus M, et al. Framing HIV Pre-Exposure Prophylaxis (PrEP) for the General Public: how inclusive messaging may prevent prejudice from Diminishing Public Support. AIDS Behav. 2016;20(7):1499–513.CrossRefPubMedPubMedCentral Calabrese SK, Underhill K, Earnshaw VA, Hansen NB, Kershaw TS, Magnus M, et al. Framing HIV Pre-Exposure Prophylaxis (PrEP) for the General Public: how inclusive messaging may prevent prejudice from Diminishing Public Support. AIDS Behav. 2016;20(7):1499–513.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Golub S. PrEP messaging: taking “Risk” out of the pitch.HIV Research for Prevention. 2018:21–5. Golub S. PrEP messaging: taking “Risk” out of the pitch.HIV Research for Prevention. 2018:21–5.
15.
Zurück zum Zitat Hoots BE, Finlayson T, Nerlander L, Paz-Bailey G, Group NHBSS, Wortley P, et al. Willingness to take, use of, and indications for pre-exposure prophylaxis among men who have sex with men—20 US cities, 2014. Clin Infect Dis. 2016;63(5):672–7.CrossRefPubMed Hoots BE, Finlayson T, Nerlander L, Paz-Bailey G, Group NHBSS, Wortley P, et al. Willingness to take, use of, and indications for pre-exposure prophylaxis among men who have sex with men—20 US cities, 2014. Clin Infect Dis. 2016;63(5):672–7.CrossRefPubMed
16.
Zurück zum Zitat Sullivan PS, Rosenberg ES, Sanchez TH, Kelley CF, Luisi N, Cooper HL, et al. Explaining racial disparities in HIV incidence in black and white men who have sex with men in Atlanta, GA: a prospective observational cohort study. Ann Epidemiol. 2015;25(6):445–54.CrossRefPubMedPubMedCentral Sullivan PS, Rosenberg ES, Sanchez TH, Kelley CF, Luisi N, Cooper HL, et al. Explaining racial disparities in HIV incidence in black and white men who have sex with men in Atlanta, GA: a prospective observational cohort study. Ann Epidemiol. 2015;25(6):445–54.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Golub SA, Gamarel KE, Surace A. Demographic differences in PrEP-Related stereotypes: implications for implementation. AIDS Behav. 2017;21(5):1229–35.CrossRefPubMedPubMedCentral Golub SA, Gamarel KE, Surace A. Demographic differences in PrEP-Related stereotypes: implications for implementation. AIDS Behav. 2017;21(5):1229–35.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Calabrese SK, Willie TC, Galvao RW, Tekeste M, Dovidio JF, Safon CB, et al. Current US guidelines for prescribing HIV pre-exposure Prophylaxis (PrEP) disqualify many women who are at risk and motivated to Use PrEP. JAIDS J Acquir Immune Defic Syndr. 2019;81(4):395–405.CrossRefPubMed Calabrese SK, Willie TC, Galvao RW, Tekeste M, Dovidio JF, Safon CB, et al. Current US guidelines for prescribing HIV pre-exposure Prophylaxis (PrEP) disqualify many women who are at risk and motivated to Use PrEP. JAIDS J Acquir Immune Defic Syndr. 2019;81(4):395–405.CrossRefPubMed
19.
Zurück zum Zitat Lancki N, Almirol E, Alon L, McNulty M, Schneider JA. Preexposure prophylaxis guidelines have low sensitivity for identifying seroconverters in a sample of young black MSM in Chicago. AIDS. 2018;32(3):383–92.CrossRefPubMed Lancki N, Almirol E, Alon L, McNulty M, Schneider JA. Preexposure prophylaxis guidelines have low sensitivity for identifying seroconverters in a sample of young black MSM in Chicago. AIDS. 2018;32(3):383–92.CrossRefPubMed
20.
Zurück zum Zitat Heads AM, Hill MJ, Suchting R, Yammine L, Gilmore-Thomas A. Predictors of anticipated PrEP stigma among women with self-reported problematic substance use: implications for Engaging Women in the PrEP Care Continuum. Arch Sex Behav. 2021;50(7):2955–64.CrossRefPubMed Heads AM, Hill MJ, Suchting R, Yammine L, Gilmore-Thomas A. Predictors of anticipated PrEP stigma among women with self-reported problematic substance use: implications for Engaging Women in the PrEP Care Continuum. Arch Sex Behav. 2021;50(7):2955–64.CrossRefPubMed
21.
Zurück zum Zitat Wilson K, Bleasdale J, Przybyla SM. Provider-patient communication on pre-exposure prophylaxis (Prep) for HIV prevention: an exploration of healthcare provider challenges. Health Commun. 2021;36(13):1677–86.CrossRefPubMed Wilson K, Bleasdale J, Przybyla SM. Provider-patient communication on pre-exposure prophylaxis (Prep) for HIV prevention: an exploration of healthcare provider challenges. Health Commun. 2021;36(13):1677–86.CrossRefPubMed
22.
Zurück zum Zitat Pinto RM, Berringer KR, Melendez R, Mmeje O. Improving PrEP implementation through Multilevel Interventions: a synthesis of the literature. AIDS Behav. 2018;22(11):3681–91.CrossRefPubMedPubMedCentral Pinto RM, Berringer KR, Melendez R, Mmeje O. Improving PrEP implementation through Multilevel Interventions: a synthesis of the literature. AIDS Behav. 2018;22(11):3681–91.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Amico KR, Bekker LG. Global PrEP roll-out: recommendations for programmatic success. The Lancet HIV. 2019;6(2):e137–e40.CrossRef Amico KR, Bekker LG. Global PrEP roll-out: recommendations for programmatic success. The Lancet HIV. 2019;6(2):e137–e40.CrossRef
24.
Zurück zum Zitat Golub SA, Fikslin RA. Recognizing and disrupting stigma in implementation of HIV prevention and care: a call to research and action. J Int AIDS Soc. 2022;25:e25930.CrossRefPubMedPubMedCentral Golub SA, Fikslin RA. Recognizing and disrupting stigma in implementation of HIV prevention and care: a call to research and action. J Int AIDS Soc. 2022;25:e25930.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Gallagher KM, Updegraff JA. Health Message Framing Effects on Attitudes, Intentions, and Behavior: a Meta-analytic review. Ann Behav Med. 2011;43(1):101–16.CrossRef Gallagher KM, Updegraff JA. Health Message Framing Effects on Attitudes, Intentions, and Behavior: a Meta-analytic review. Ann Behav Med. 2011;43(1):101–16.CrossRef
26.
Zurück zum Zitat Calabrese SK. Understanding, contextualizing, and addressing PrEP stigma to enhance PrEP implementation. Curr HIV/AIDS Rep. 2020;17(6):579–88.CrossRefPubMed Calabrese SK. Understanding, contextualizing, and addressing PrEP stigma to enhance PrEP implementation. Curr HIV/AIDS Rep. 2020;17(6):579–88.CrossRefPubMed
27.
Zurück zum Zitat Guilamo-Ramos V, Thimm-Kaiser M, Benzekri A, Futterman D. Youth at risk of HIV: the overlooked US HIV prevention crisis. The Lancet HIV. 2019;6(5):e275–e8.CrossRefPubMed Guilamo-Ramos V, Thimm-Kaiser M, Benzekri A, Futterman D. Youth at risk of HIV: the overlooked US HIV prevention crisis. The Lancet HIV. 2019;6(5):e275–e8.CrossRefPubMed
29.
Zurück zum Zitat Skolnik AA, Bokhour BG, Gifford AL, Wilson BM, Van Epps P. Roadblocks to PrEP: what Medical Records Reveal about Access to HIV Pre-exposure Prophylaxis. J Gen Intern Med. 2020;35(3):832–8.CrossRefPubMed Skolnik AA, Bokhour BG, Gifford AL, Wilson BM, Van Epps P. Roadblocks to PrEP: what Medical Records Reveal about Access to HIV Pre-exposure Prophylaxis. J Gen Intern Med. 2020;35(3):832–8.CrossRefPubMed
30.
Zurück zum Zitat Turner D, Lockhart E, Wang W, Shore R, Daley EM, Marhefka SL. PrEP Implementation Behaviors of Community-Based HIV Testing Staff: A Mixed-Methods Approach Using Latent Class Analysis. Journal of Acquired Immune Deficiency Syndromes (1999). 2020;83(5):467 – 74. Turner D, Lockhart E, Wang W, Shore R, Daley EM, Marhefka SL. PrEP Implementation Behaviors of Community-Based HIV Testing Staff: A Mixed-Methods Approach Using Latent Class Analysis. Journal of Acquired Immune Deficiency Syndromes (1999). 2020;83(5):467 – 74.
31.
Zurück zum Zitat Adams LM, Balderson BH, Brown K, Bush SE, Packett BJ. Who starts the conversation and who receives Preexposure Prophylaxis (PrEP)? A brief online survey of Medical Providers’ PrEP Practices. Health Educ Behav. 2018;45(5):723–9.CrossRefPubMed Adams LM, Balderson BH, Brown K, Bush SE, Packett BJ. Who starts the conversation and who receives Preexposure Prophylaxis (PrEP)? A brief online survey of Medical Providers’ PrEP Practices. Health Educ Behav. 2018;45(5):723–9.CrossRefPubMed
32.
Zurück zum Zitat Gamarel KE, Golub SA. Sexual goals and perceptions of goal congruence in individuals’ PrEP adoption decisions: a mixed-methods study of gay and bisexual men who are in primary relationships. Ann Behav Med. 2020;54(4):237–48.CrossRefPubMed Gamarel KE, Golub SA. Sexual goals and perceptions of goal congruence in individuals’ PrEP adoption decisions: a mixed-methods study of gay and bisexual men who are in primary relationships. Ann Behav Med. 2020;54(4):237–48.CrossRefPubMed
33.
Zurück zum Zitat Fisher CB, Fried AL, Desmond M, Macapagal K, Mustanski B. Facilitators and barriers to participation in PrEP HIV Prevention trials involving Transgender Male and female adolescents and emerging adults. AIDS Educ Prev. 2017;29(3):205–17.CrossRefPubMedPubMedCentral Fisher CB, Fried AL, Desmond M, Macapagal K, Mustanski B. Facilitators and barriers to participation in PrEP HIV Prevention trials involving Transgender Male and female adolescents and emerging adults. AIDS Educ Prev. 2017;29(3):205–17.CrossRefPubMedPubMedCentral
Metadaten
Titel
Missed Opportunities When We Focus only on Risk: Using the Concerns Based Conversation Starter to Identify Potential PrEP Candidates
verfasst von
Megan Mueller Johnson
Noah Brooks
K Rivet Amico
Publikationsdatum
24.01.2023
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 8/2023
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-023-03993-6

Weitere Artikel der Ausgabe 8/2023

AIDS and Behavior 8/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.